Indian pharma industry likely to grow at 10-13 per cent in FY'21: Icra

The expected growth in the next financial year is on the back of healthy demand from the domestic market given increasing spend on healthcare along with improving access, Icra said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/36wYfk7
via IFTTT